DUPONT DE NEMOURS, INC. (DD) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2023-03-31..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2023-03-31..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2023-03-31..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2023-03-31..
Free cash flow
Overview →Financial period ending 2023-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $722.00M | Cash generated by operating activities. Period ending 2023-03-31. |
| Operating cash flow / net income · 12 months | 0.13× | Operating cash flow / net income. Period ending 2023-03-31. $722.00M ÷ $5.64B ≈ 0.13× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 722.00M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Revenue | 12.76B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 5.64B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | (m) | (m) | $722.00M | (m) | (m) | $12.76B | (m) | $5.64B | (m) | (m) | (m) | 0.13× |
| 2022-12-31 | (m) | (m) | $588.00M | (m) | (m) | $13.02B | (m) | $5.87B | (m) | (m) | (m) | 0.10× |
| 2022-09-30 | (m) | (m) | $1.33B | (m) | (m) | $17.25B | (m) | $1.85B | (m) | (m) | (m) | 0.72× |
| 2022-06-30 | (m) | (m) | $1.76B | (m) | (m) | $17.13B | (m) | $1.87B | (m) | (m) | (m) | 0.94× |
| 2022-03-31 | (m) | (m) | $2.11B | (m) | (m) | $16.91B | (m) | $1.56B | (m) | (m) | (m) | 1.35× |
| 2021-12-31 | (m) | (m) | $2.28B | (m) | (m) | $16.65B | (m) | $6.47B | (m) | (m) | (m) | 0.35× |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | $16.13B | (m) | $6.49B | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | $13.50B | (m) | $6.01B | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $13.69B | (m) | $3.06B | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $4.09B | (m) | (m) | $14.34B | (m) | $-2.95B | (m) | (m) | (m) | -1.39× |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $9.72B | (m) | $-3.00B | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $1.41B | (m) | (m) | $15.44B | (m) | $498.00M | (m) | (m) | (m) | 2.83× |
| 2019-03-31 | (m) | (m) | $6.89B | (m) | (m) | $84.12B | (m) | $3.26B | (m) | (m) | (m) | 2.11× |
| 2018-12-31 | (m) | (m) | $4.73B | (m) | (m) | $85.98B | (m) | $3.84B | (m) | (m) | (m) | 1.23× |
| 2018-09-30 | (m) | (m) | $10.85B | (m) | (m) | $85.94B | (m) | $2.11B | (m) | (m) | (m) | 5.15× |
| 2018-06-30 | (m) | (m) | $8.75B | (m) | (m) | $81.17B | (m) | $2.12B | (m) | (m) | (m) | 4.12× |
| 2018-03-31 | (m) | (m) | $6.63B | (m) | (m) | $70.76B | (m) | $1.68B | (m) | (m) | (m) | 3.96× |
| 2017-12-31 | (m) | (m) | $8.70B | (m) | (m) | $62.48B | (m) | $1.46B | (m) | (m) | (m) | 5.96× |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | $52.57B | (m) | $3.06B | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | $50.69B | (m) | $4.95B | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $5.60B | (m) | (m) | $48.16B | (m) | $4.32B | (m) | (m) | (m) | 1.30× |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $7.61B | (m) | (m) | $48.78B | (m) | $7.68B | (m) | (m) | (m) | 0.99× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DOW INC. (DOW) | United States | $20.577B | -11.55 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| EASTMAN CHEMICAL CO (EMN) | United States | $7.575B | 17.34 |
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |